NO162156C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinonderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinonderivater

Info

Publication number
NO162156C
NO162156C NO844441A NO844441A NO162156C NO 162156 C NO162156 C NO 162156C NO 844441 A NO844441 A NO 844441A NO 844441 A NO844441 A NO 844441A NO 162156 C NO162156 C NO 162156C
Authority
NO
Norway
Prior art keywords
tiadiazino
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO844441A
Other languages
English (en)
Norwegian (no)
Other versions
NO844441L (no
NO162156B (no
Inventor
William John Coates
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NO844441L publication Critical patent/NO844441L/no
Publication of NO162156B publication Critical patent/NO162156B/no
Publication of NO162156C publication Critical patent/NO162156C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/34Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic
    • C07C65/36Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic containing rings other than six-membered aromatic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO844441A 1983-11-08 1984-11-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinonderivater NO162156C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838329784A GB8329784D0 (en) 1983-11-08 1983-11-08 Heterocyclic compounds

Publications (3)

Publication Number Publication Date
NO844441L NO844441L (no) 1985-05-09
NO162156B NO162156B (no) 1989-08-07
NO162156C true NO162156C (no) 1989-11-15

Family

ID=10551429

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844441A NO162156C (no) 1983-11-08 1984-11-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinonderivater

Country Status (21)

Country Link
US (1) US4616013A (xx)
EP (1) EP0145236A3 (xx)
JP (1) JPS60115570A (xx)
KR (1) KR850003889A (xx)
CN (1) CN85101925A (xx)
AU (1) AU572221B2 (xx)
CA (1) CA1251205A (xx)
DK (1) DK525884A (xx)
ES (1) ES8702392A1 (xx)
FI (1) FI844374L (xx)
GB (1) GB8329784D0 (xx)
GR (1) GR80843B (xx)
HU (1) HU192999B (xx)
IL (1) IL73429A (xx)
JO (1) JO1341B1 (xx)
NO (1) NO162156C (xx)
NZ (1) NZ210123A (xx)
PH (1) PH21682A (xx)
PT (1) PT79456B (xx)
ZA (1) ZA848407B (xx)
ZW (1) ZW17484A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724962D0 (en) * 1987-10-24 1987-11-25 Smith Kline French Lab Heterocyclic compounds
GB8610369D0 (en) * 1986-04-28 1986-06-04 Smith Kline French Lab Heterocyclic compounds
US4861773A (en) * 1986-04-28 1989-08-29 Smith Kline & French Laboratories Limited Heterocyclic compounds
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
JP4932523B2 (ja) * 2007-01-23 2012-05-16 株式会社吉野工業所 ポンプ付き容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3464988A (en) * 1968-01-11 1969-09-02 Bristol Myers Co 3-hydrazinobenzo(h)cinnolines and 3 - hydrazinobenzocyclohepta-(5,6-c)pyridazines
EP0052442B1 (en) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclic compounds
US4489074A (en) * 1982-11-12 1984-12-18 Imperial Chemical Industries, Plc 1,3,4-Thiadiazin-2-ones
US4602019A (en) * 1983-04-22 1986-07-22 Warner-Lambert Company Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents

Also Published As

Publication number Publication date
FI844374A0 (fi) 1984-11-07
JPS60115570A (ja) 1985-06-22
CN85101925A (zh) 1987-01-24
PH21682A (en) 1988-01-13
HUT37930A (en) 1986-03-28
GB8329784D0 (en) 1983-12-14
ZA848407B (en) 1985-06-26
JO1341B1 (en) 1986-11-30
ES8702392A1 (es) 1987-01-01
ZW17484A1 (en) 1985-05-29
NO844441L (no) 1985-05-09
EP0145236A3 (en) 1988-03-30
EP0145236A2 (en) 1985-06-19
GR80843B (en) 1985-03-05
AU3515884A (en) 1985-05-16
AU572221B2 (en) 1988-05-05
IL73429A0 (en) 1985-02-28
KR850003889A (ko) 1985-06-29
CA1251205A (en) 1989-03-14
PT79456B (en) 1986-11-14
NO162156B (no) 1989-08-07
NZ210123A (en) 1987-05-29
DK525884A (da) 1985-05-09
IL73429A (en) 1987-10-20
DK525884D0 (da) 1984-11-05
FI844374L (fi) 1985-05-09
US4616013A (en) 1986-10-07
ES537438A0 (es) 1987-01-01
PT79456A (en) 1984-12-01
HU192999B (en) 1987-08-28

Similar Documents

Publication Publication Date Title
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO843979L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO172581C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO171913C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser
NO164301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO843084L (no) Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO843042L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kumarin-derivater
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.